On reimbursement reforms and stockpiling of prescription drugs: The case of insulin
Health Policy, 06/01/2012
Skipper N – Using before–and–after comparisons to identify the price responsiveness of prescription drug demand can be very misleading, when changes in co–payments are announced.



